MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/idr.s246174

Медицинская библиотека · Infection and drug resistance · 2021

Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales.

Tan Xing, Kim Hwan Seung, Baugh Kimberly, Huang Yanqin, Kadiyala Neeraja, Wences Marisol, Singh Nidhi, Wenzler Eric, Bulman Zackery P

СтатьяОбзорПеревод в очереди

Аннотация

The spread of metallo-β-lactamase (MBL)-producing Enterobacterales worldwide without the simultaneous increase in active antibiotics makes these organisms an urgent public health threat. This review summarizes recent advancements in diagnostic and treatment strategies for infections caused by MBL-producing Enterobacterales. Adequate treatment of patients infected with MBL-producing Enterobacterales relies on detection of the β-lactamase in the clinic. There are several molecular platforms that are currently available to identify clinically relevant MBLs as well as other important serine-β-lactamases. Once detected, there are several antibiotics that have historically been used for the treatment of MBL-producing Enterobacterales. Antimicrobials such as aminoglycosides, tetracyclines, fosfomycin, and polymyxins often show promising in vitro activity though clinical data are currently lacking to support their widespread use. Ceftazidime-avibactam combined with aztreonam is promising for treatment of infections caused by MBL-producing Enterobacterales and currently has the most clinical data of any available antibiotic to support its use. While cefiderocol has displayed promising activity against MBL-producing Enterobacterales in vitro and in preliminary clinical studies, further clinical studies will better shed light on its place in treatment. Lastly, there are several promising MBL inhibitors in the pipeline, which may further improve the treatment of MBL-producing Enterobacterales.

Для цитирования: Tan Xing, Kim Hwan Seung, Baugh Kimberly, Huang Yanqin, Kadiyala Neeraja, Wences Marisol, Singh Nidhi, Wenzler Eric, Bulman Zackery P. Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales.. Infection and drug resistance. 2021. DOI: 10.2147/idr.s246174.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.